HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Drug action on cerebral energy state during and after various hypoxic conditions.

Abstract
The behaviour of fuels (glycogen, glucose), of glycolytic pathway intermediates (glucose-6-phosphate, pyruvate) and end-product (lactate), as well as the pool of labile phosphates (ATP, ADP, AMP, creatine phosphate) and the energy charge of the brain were studied in the motor area of the cerebral cortex of beagle dogs. These parameters were evaluated both after various hypoxic conditions (hypoxic hypoxia, hypoxia plus complete or incomplete ischemia) and after 3, 15 or 30 min of post-hypoxic recovery and recirculation. The effect of some drugs (papaverine, UDP-glucose, (-)eburnamonine, suloctidil) following intracarotid perfusion has been evaluated in the various quoted experimental conditions. The tested drugs proved unable to improve the deranged brain metabolism under all the hypoxic conditions. On the contrary, an activating effect of suloctidil and (-)eburnamonine could be observed during the recovery after both hypoxia and hypoxia plus complete ischemia, papaverine being ineffective and UDP-glucose increasing the glycogen synthesis. The drugs proved unable to induce a restitution of the altered brain metabolism after hypoxia plus incomplete ischemia.
AuthorsG Benzi, E Arrigoni, F Dagani, F Marzatico, A Manzini, O Pastoris, R F Villa
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 236 Issue 2 Pg. 234-51 (Dec 1978) ISSN: 0003-9780 [Print] Belgium
PMID747471 (Publication Type: Journal Article)
Chemical References
  • Adenosine Triphosphate
  • Glycogen
  • Glucose
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Brain (metabolism)
  • Brain Chemistry (drug effects)
  • Dogs
  • Energy Metabolism (drug effects)
  • Female
  • Glucose (metabolism)
  • Glycogen (metabolism)
  • Hypoxia (metabolism)
  • Ischemia (metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: